Omkar Speciality Chemicals Issues Clarification on Record Date for April 15 Meeting

2 min read     Updated on 14 Apr 2026, 05:05 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Omkar Speciality Chemicals issued a clarificatory intimation regarding its April 15, 2026 monitoring committee meeting, stating that this date will not serve as the record date. The company will fix a revised record date during the meeting with mandatory 7 working days gap compliance, while proceeding with planned equity restructuring and new share issuance worth INR 5,00,00,000.

powered bylight_fuzz_icon
37192100

*this image is generated using AI for illustrative purposes only.

Omkar Speciality Chemicals Limited has issued a clarificatory intimation regarding its monitoring committee meeting scheduled for April 15, 2026, addressing important revisions to the previously announced record date arrangements. The company, which entered Corporate Insolvency Resolution Process (CIRP) on December 5, 2022, provided this update to ensure regulatory compliance under SEBI listing obligations.

Record Date Clarification

In a formal communication dated April 14, 2026, the company clarified two critical points regarding the upcoming monitoring committee meeting:

Clarification: Details
Original Assumption: April 15, 2026 was not intended as record date
Revised Process: Record date to be fixed during the meeting
Compliance Requirement: Minimum 7 working days gap from meeting date
Communication Method: Outcome to be intimated via stock exchange

Meeting Agenda and Restructuring Plans

The monitoring committee meeting will address several critical corporate restructuring matters under the supervision of Chairperson Mr. Ajit Kumar, the erstwhile Resolution Professional. The committee will consider multiple significant proposals that reflect the company's ongoing restructuring process under the approved resolution plan.

Equity Share Restructuring

The committee will determine record dates for extinguishment and cancellation of existing equity shares in accordance with the approved scheme:

Share Category: Details
Promoter Shares: Entire equity shares of INR 10.00 each, fully paid up
Public Shareholder Shares: Entire equity shares of INR 10.00 each, fully paid up
Action: Complete extinguishment/cancellation

New Share Issuance

A major agenda item involves approving the issuance of new equity shares under the resolution plan:

Parameter: Details
Number of Shares: 50,00,000 equity shares
Face Value: INR 10.00 each
Issue Price: At par
Total Consideration: INR 5,00,00,000
Issuance Method: Private Placement Basis

Key Appointments and Operational Matters

The committee will consider appointing key management personnel to strengthen the company's operational framework:

Position: Appointee Details
Chief Financial Officer: Mr. Mahendra Kumar Jain (PAN: AYHPJ9945Q)
Company Secretary & Compliance Officer: Mr. Kuldeep Menaria (Membership No. ACS: 68041)

The meeting will also address borrowing arrangements through loan agreements without conversion options into securities, along with reviewing statutory and contractual compliances and adjustment of CIRP costs.

Corporate Background

Omkar Speciality Chemicals Limited, incorporated with CIN L24110MH2005PLC151589, is registered in Badlapur, Maharashtra. The company entered CIRP through an order dated December 5, 2022, under case IA 1521/2022 In C.P. (IB)/1738(MB)2017. The monitoring committee is chaired by Mr. Ajit Kumar, who continues to oversee the company's restructuring process from his office at Ocus Quantum, Sector 51, Gurugram.

What impact will the complete extinguishment of existing equity shares have on current shareholders' ownership rights and potential compensation?

How will the private placement of 50 lakh new equity shares at par value affect the company's ownership structure and control dynamics?

What are the expected timelines for Omkar Speciality Chemicals to exit the CIRP process and resume normal business operations?

Omkar Speciality Chemicals' Monitoring Committee Holds Inaugural Meeting Post-NCLT Approval

2 min read     Updated on 13 Aug 2025, 08:04 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Omkar Speciality Chemicals Limited (OSCL) held the first meeting of its Monitoring Committee on August 13, marking a crucial step in its corporate restructuring process. The committee, formed after NCLT's approval of the company's resolution plan, appointed Ajit Kumar as Chairman. Key discussions included regulatory compliance, financial considerations, CIRP cost analysis, and insurance claims. This development follows OSCL's admission into CIRP on December 5, 2022, and represents a significant move towards implementing the approved resolution plan and restoring financial stability.

powered bylight_fuzz_icon
16641278

*this image is generated using AI for illustrative purposes only.

Omkar Speciality Chemicals Limited (OSCL) has taken a significant step forward in its corporate restructuring process with the first meeting of its Monitoring Committee. The committee, formed following the National Company Law Tribunal's (NCLT) approval of the company's resolution plan, convened on August 13, marking a crucial milestone in OSCL's journey towards financial stability.

Key Developments

The inaugural meeting, which lasted for two hours, addressed several critical aspects of the company's path forward:

  1. Leadership Appointment: Ajit Kumar was appointed as the Chairman of the Monitoring Committee. Kumar, who previously served as the Resolution Professional, will now oversee the implementation of the approved resolution plan.

  2. Regulatory Compliance: The committee discussed essential statutory compliances with various regulatory bodies, including the Registrar of Companies (ROC), Goods and Services Tax (GST) authorities, Income Tax department, and stock exchanges.

  3. Financial Considerations: Determination of fees for the Chairman and other implementation-related costs were on the agenda, highlighting the committee's focus on financial prudence.

  4. CIRP Cost Analysis: The meeting reviewed Corporate Insolvency Resolution Process (CIRP) costs under both "process-related" and "going concern" categories, ensuring transparency in the financial restructuring process.

  5. Insurance Claims: The committee also addressed matters related to insurance claims, though specific details were not disclosed.

Background and Future Outlook

OSCL was admitted into the Corporate Insolvency Resolution Process (CIRP) on December 5, 2022, following an order by the NCLT Mumbai Bench. The recent approval of the resolution plan on July 31 paved the way for the formation of the Monitoring Committee.

The committee's formation and its inaugural meeting represent critical steps in OSCL's efforts to navigate through its financial challenges and implement the NCLT-approved resolution plan effectively. The focus on regulatory compliance and cost management indicates a structured approach towards the company's revival.

Monitoring Committee Structure

The Monitoring Committee, constituted in compliance with the approved resolution plan, comprises key stakeholders tasked with overseeing the implementation process. Ajit Kumar, as the Chairperson, brings his experience as the erstwhile Resolution Professional to guide the committee's efforts.

Looking Ahead

As Omkar Speciality Chemicals moves forward with its restructuring process, the Monitoring Committee is expected to play a pivotal role in ensuring the smooth implementation of the resolution plan. Future meetings will likely focus on tracking progress, addressing challenges, and steering the company towards operational and financial stability.

The company's stakeholders, including investors and creditors, will be keenly watching the developments as OSCL works towards revitalizing its operations and restoring its market position in the specialty chemicals sector.